Physician profile
Michael Zhang
NPI 1972967917
$10,148.16
in general payments reported to CMS, 2019-2025
11 companies · $3,902 in 2025
The $3,902 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,943 · 2024: $2,303 · 2025: $3,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,251 · Food and Beverage: $2,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,250.61 |
| Food and Beverage | $2,897.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,029.00 | 2023-2025 | Other - Miscellaneous, Battalion Tlif - PC, Lif |
| Globus Medical, INC. | $1,657.07 | 2023-2025 | Excelsius Gps, Creo 5.5, Mars 3v/3vl |
| Nuvasive, INC. | $1,494.03 | 2023 | Tlif, Xlif, Simplify Cervical Artificial Disc |
| Evolution Surgical, INC | $1,088.44 | 2025 | |
| Stryker Corporation | $454.59 | 2023-2024 | Everest Spinal System, Canyon Retractor Systems, Cascadia Interbody System |
| Gt Medical Technologies, INC | $426.23 | 2023-2024 | Gammatile, Gammatile |
| Arthrex, INC. | $409.21 | 2025 | |
| Medtronic, INC. | $288.76 | 2023-2025 | Stealth Autoguide System, O-Arm |
| Novocure INC. | $149.49 | 2025 | |
| Siemens Medical Solutions USA, INC. | $134.68 | 2025 | |
| Genentech USA, INC. | $16.66 | 2024 | Ocrevus, Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.